Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), sold 1,600 shares at $262.61 ($418K) on 2022-11-17, disclosed to the SEC on 2022-11-18.
Scheduled sale ($418k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $261.05 | 1,500 | $392K | 93.7% |
| 2 | $262.61 | 100 | $26K | 6.3% |
| Total | $261.15 avg | 1,600 | $418K | 100% |
| Filing → |
| UTHR | SELL | 2025-12-16 | $496K | — | Filing → |
| UTHR | SELL | 2025-03-20 | $3.0M | — | Filing → |
| UTHR | SELL | 2025-01-13 | $3.3M | — | Filing → |